Microvesicular inflammasomes: role in sepsis
Microvesicular inflammasomes: role in sepsis
批准号:
8888121
负责人:
Anasuya Sarkar
金额:
$30.42万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-08-15 至 2019-05-31
关键词:
AffectApoptosisApoptoticBiological MarkersBiologyCaspaseCaspase-1Cell CommunicationCell DeathCell physiologyCellsCessation of lifeClinicClinical TrialsComplexDiseaseDistantEncapsulatedEndotoxinsEnzymesEventFailureFigs - dietaryFunctional disorderGoalsHealthHealth Care CostsImmuneImmune responseImmunologicsIn VitroInduction of ApoptosisInfectionInflammationInflammatoryInjuryIntegration Host FactorsInterleukin-18KnowledgeLifeLinkLungLymphocyteLymphocyte DepletionMediatingMolecularMononuclearMusNF-kappa BOrganOutcomePathogenesisPathologicPathway interactionsPatientsPeripheral Blood LymphocytePhagocytesProcessProductionPublic HealthReactionRegulationResolutionResourcesRoleSepsisSeveritiesSeverity of illnessSignal TransductionSystemTestingTherapeuticTissuesUnited StatesVesicleWorkcell injurycytokinefunctional lossimprovedin vivoinsightinterleukin-1beta-converting enzyme inhibitormacrophagemicrobialmodel designmonocytenovelnovel therapeuticspathogenpreventprogramspublic health relevanceresponserole modelsensorsepticuptake
中文摘要
描述(由申请人提供):仅在美国,每年就有超过500,000人发生败血症,导致175,000人死亡。先天宿主反应的复杂性及其与确定对病原体和危险信号的最终反应的相关性与脓毒症反应特别相关。近年来,细胞损伤和凋亡被认为是脓毒症免疫应答的关键调节因子。虽然对脓毒症中细胞损伤和死亡的发病机制了解很多,但我们的知识中存在一些空白;因此,目前没有有效的药物治疗。在这种情况下,称为半胱天冬酶的酶是完成凋亡程序所必需的。吞噬细胞,特别是单核细胞/巨噬细胞,被认为是肺中炎症和免疫反应的主要组分,并且是胱天蛋白酶,特别是胱天蛋白酶-1的丰富储存库。caspase-1的功能已被认为超出了IL-10和IL-18的加工和激活,包括调节NF-κ B和诱导细胞凋亡。目前的建议旨在扩大我们最近的观察,即微泡半胱天冬酶-1可以从单核吞噬细胞释放,对靶细胞有远距离的影响。目前的建议旨在调查一种新的假说,凋亡酶,半胱天冬酶-1,封装在循环囊泡,细胞损伤和凋亡。这一建议提供了一个非常需要的努力和框架,以研究脓毒症患者脾脏和外周血淋巴细胞耗竭的机制知之甚少,提高我们对细胞损伤的分子机制的理解,并提供新的治疗机会,以阻止脓毒症患者的器官破坏。因此,为了确定
本研究的主要目的是:1)明确caspase-1在炎症小体激活过程中对脓毒症的调控作用。2)阐明严重脓毒症时单核吞噬细胞释放的caspase-1调节淋巴细胞存活和功能的机制; 3)确定caspase-1介导的淋巴细胞丢失是否预测脓毒症患者的临床结局。这项工作的成功完成将揭示微泡caspase-1和炎性体信号传导的关键组分,增强我们对细胞损伤潜在分子机制的理解,并提供新的治疗机会来阻止脓毒症患者的器官破坏。
英文摘要
DESCRIPTION (provided by applicant): Over 500,000 people develop sepsis annually in United States alone, resulting in 175,000 fatalities. The complexity of the innate host response and its relevance to determining the ultimate response to pathogens and danger signals is particularly relevant to the sepsis response. Recently, cell injury and apoptosis has been described as key regulator of immune responses in sepsis. Although much is known about the pathogenesis of cell injury and death in sepsis, there are several gaps in our knowledge; as a result of which there is currently no effective pharmacologic therapy. In this context, enzymes known as caspases are essential for completion of the apoptotic program. Phagocytes, in particular monocyte/macrophages, are recognized as major components of inflammatory and immunologic reactions in the lung and are rich reservoirs of caspases, especially caspase-1. The function of caspase-1 has recently been recognized to extend beyond the processing and activation of IL-1ß and IL-18 to include regulation of NF-kB and induction of apoptosis. The present proposal seeks to expand upon our recent observation that microvesicular caspase-1 can be released from mononuclear phagocytes to have distant effects on target cells. The present proposal seeks to investigate a novel hypothesis that links the apoptotic enzyme, caspase-1, encapsulated in circulatory vesicles, to cell injury and apoptosis. This proposal provides a much needed effort and framework to study the poorly understood mechanism of splenic and peripheral blood lymphocyte depletion in septic patients, enhance our understanding of the molecular mechanisms underlying the cell injury and provide new therapeutic opportunities to halt the organ destruction in septic patients. Therefore, to determine
the specifics of this novel pathway, we propose the following specific aims: 1) To identify the role of caspase-1 in regulating sepsis response via inflammasome activation events., 2) To elucidate the mechanisms by which caspase-1 released from mononuclear phagocyte regulates lymphocyte survival and function in severe sepsis and 3) To determine if caspase-1 mediated lymphocyte loss predicts clinic outcomes in septic patients This proposal provides an opportunity to examine the role of caspase-1 in the complex biology of cell interactions and apoptosis. Successful completion of this work will uncover critical components of microvesicular caspase-1 and inflammasome signaling enhance our understanding of the molecular mechanisms underlying the cell injury and provide new therapeutic opportunities to halt the organ destruction in septic patients.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
GasderminD regulation of Acute Lung Injury
-
批准号:10677806
-
项目类别:
-
资助金额:$55.07万
-
财政年份:2022
-
负责人:Anasuya Sarkar
-
依托单位:
Microparticulate Caspase-1 mediated Lung Injury.
-
批准号:8963727
-
项目类别:
-
资助金额:$38.5万
-
财政年份:2015
-
负责人:Anasuya Sarkar
-
依托单位:
ARDS: Injury from Microvesicular Caspase-1
-
批准号:8049628
-
项目类别:
-
资助金额:$22.88万
-
财政年份:2010
-
负责人:Anasuya Sarkar
-
依托单位:
ARDS: Injury from Microvesicular Caspase-1
-
批准号:7875026
-
项目类别:
-
资助金额:$19.06万
-
财政年份:2010
-
负责人:Anasuya Sarkar
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: